Abstract
Two large historical cohort studies, Control of Renal Osteodystrophy in South America (CORES) and Analyzing Data, Recognizing Excellence and Optimizing Outcome (ARO), are published in this issue of Nephrology Dialysis Transplantation. Both describe associations between biochemical measures of chronic kidney disease–mineral bone disease (CKD–MBD) which add usefully to the body of evidence already published in this and related fields. Hitherto, studies of this type have, with the exception of those derived from the Dialysis Outcomes and Practice Patterns (DOPPS) study, reflected data acquired from large US-based populations receiving maintenance dialysis. In contrast, the studies under discussion here have utilized patient groups with potentially important demographic differences—the CORES study is based exclusively on South American cohorts and is hence multiracial, and the ARO study on a European cohort which includes significant numbers of patients from Eastern Europe. Together 24 000 patients were studied which provides weight to their observational studies.

This publication has 6 references indexed in Scilit: